We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 4,484 results
  1. Associations of perfluoroalkyl substances (PFAS) with lipid and lipoprotein profiles

    Background

    Perfluoroalkyl substances (PFAS) are man-made chemicals with unique properties that are widely distributed in humans and the environment....

    Marianne Haug, Linda Dunder, ... Samira Salihovic in Journal of Exposure Science & Environmental Epidemiology
    Article Open access 05 April 2023
  2. A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time

    Background

    Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g....

    Hayato Isobe, Masashi Shimoda, ... Hideaki Kaneto in BMC Endocrine Disorders
    Article Open access 09 June 2021
  3. An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort

    A disorder of lipid metabolism is involved in cardiovascular diseases including hypertension. A high level of small dense low-density lipoprotein...

    Marenao Tanaka, Tatsuya Sato, ... Masato Furuhashi in Hypertension Research
    Article 02 August 2023
  4. Evaluation of the therapeutic potentials of extract fractions of Vernonia calvoana on streptozotocin-induced diabetic rats: approach through in silico, in vitro and in vivo studies

    Background

    Diabetes is a serious metabolic disorder and many medicinal plants are used in traditional medicine to manage it. This study aimed to...

    Iwara Arikpo Iwara, Victor S. Ekam, ... Mbeh Eteng Ubana in Beni-Suef University Journal of Basic and Applied Sciences
    Article Open access 25 September 2023
  5. Quantification of LDL-Cholesterol Corrected for Molar Concentration of Lipoprotein(a)

    Purpose

    Cholesterol in lipoprotein(a) [Lp(a)-C] is commonly estimated as 30% of the measured Lp(a) mass. However, difficulties in the accurate...

    Robert S. Rosenson, J. Antonio G. López, ... Santica M. Marcovina in Cardiovascular Drugs and Therapy
    Article Open access 26 November 2022
  6. Clinical prognostic impact of C-NLR in heart failure patients with different ejection fractions: a retrospective study

    Objection

    Inflammatory conditions and immune disorders may worsen the prognosis of chronic heart failure (CHF) patients. The aim of this study was to...

    Fazhi Yang, Lihua Zhang, ... Lixing Chen in BMC Cardiovascular Disorders
    Article Open access 17 January 2024
  7. Nelsonia canescens (Acanthaceae) aqueous extract and partitioned fractions ameliorates type-2 diabetes in alloxan-induced diabetic rats

    Background

    Diabetes mellitus is a metabolic disorder that affects the body’s ability to produce or use insulin. There is a continuous rise of this...

    Augustine Innalegwu Daniel, Theresa Yebo Gara, ... Ashwil Klein in Future Journal of Pharmaceutical Sciences
    Article Open access 12 December 2022
  8. High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

    Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease...

    Zhi-Wei Mo, Yue-Ming Peng, ... **g-Song Ou in Signal Transduction and Targeted Therapy
    Article Open access 14 August 2023
  9. Executive functioning and serum lipid fractions in Parkinson’s disease—a possible sex-effect: the PACOS study

    The association between dyslipidemia and cognitive performance in Parkinson’s disease (PD) patients still needs to be clarified. Aim of the study was...

    Antonina Luca, Roberto Monastero, ... Alessandra Nicoletti in Journal of Neural Transmission
    Article Open access 13 January 2022
  10. Impact of anti-oestrogen therapy on lipoprotein(a) in postmenopausal women: a systematic review and meta-analysis of double-blind placebo-controlled clinical studies

    Purpose

    The potential mechanisms of endocrine therapy for thrombosis remain currently unclear, and more studies are warranted for further...

    Federica Fogacci, Claudio Borghi, ... Arrigo F. G. Cicero in Endocrine
    Article 21 December 2022
  11. Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery

    Introduction

    Obesity is a chronic disease associated with other comorbidities, including atherogenic dyslipidemia (AD). Bariatric surgery (BS) has...

    Elena González Arnáiz, María D. Ballesteros Pomar, ... Isidoro Cano Rodríguez in Obesity Surgery
    Article 10 July 2021
  12. Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

    Background

    Lp-PLA2 is linked to cardiovascular diseases and poor outcomes, especially in diabetes, as it functions as a pro-inflammatory and oxidative...

    Shudong Zhang, Jiangang Wang, ... Qiu**g Chen in BMC Cardiovascular Disorders
    Article Open access 14 May 2024
  13. Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis

    It has been demonstrated that pitavastatin can significantly reduce low-density lipoprotein (LDL) cholesterol (LDL-C), but its impact on lipoprotein...

    Rui-xia Xu, Yan Zhang, ... Jian-jun Li in Current Medical Science
    Article 29 October 2020
  14. Estimating the Effect of Aerobic Exercise Training on Novel Lipid Biomarkers: A Systematic Review and Multivariate Meta-Analysis of Randomized Controlled Trials

    Background

    Aerobic exercise training (AET) prescribed as lipid management treatment positively affects the standard lipid profile and reduces...

    Gina Wood, Emily Taylor, ... Neil A. Smart in Sports Medicine
    Article Open access 02 March 2023
  15. Circ_0026218 ameliorates oxidized low-density lipoprotein-induced vascular endothelial cell dysfunction by regulating miR-188-3p/TLR4/NF-κB pathway

    Background

    Circular RNAs (circRNAs) have shown important regulatory roles in cardiovascular diseases, including atherosclerosis (AS). However, the...

    **g Liu, **angyang Zhang, ... Tieliang Zhang in Cardiovascular Drugs and Therapy
    Article 31 December 2022
  16. Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus

    Purpose

    To determine the population attributable fraction (PAF) of fatty liver disease (FLD) for type 2 diabetes mellitus (T2DM) and compare it to the...

    **gyuan Xu, Longyun Wu, ... **aolan Lu in BMC Endocrine Disorders
    Article Open access 19 September 2023
  17. Amelioration of diabetes and its complications by Manilkara zapota (L) P. Royen fruit peel extract and its fractions in alloxan and STZ-NA induced diabetes in Wistar rats

    Purpose

    This study aims to evaluate the effects of Manilkara zapota (L) P. Royen fruit peel extract (EMZFP) and its fractions in ameliorating...

    Pravin P. Karle, Shashikant C. Dhawale, Vijay V. Navghare in Journal of Diabetes & Metabolic Disorders
    Article 04 February 2022
  18. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America

    Background

    Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant disease caused by mutations in APOE , the gene which encodes apolipoprotein...

    Joaquim Nelito da Silveira-Neto, Guilherme **son de Oliveira Ahn, ... Luiz Fernando Onuchic in Diagnostic Pathology
    Article Open access 26 July 2021
  19. Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study

    Sara Sokooti, José L. Flores-Guerrero, ... Robin P. F. Dullaart in Diabetologia
    Article Open access 20 November 2021
  20. Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease

    Purpose of Review

    Implementation of intensive LDL cholesterol (LDL-C) lowering strategies and recognition of the role of triglyceride-rich...

    Chris J. Packard in Current Atherosclerosis Reports
    Article Open access 17 February 2022
Did you find what you were looking for? Share feedback.